Details for Patent: 8,227,507

Summary for Patent: 8,227,507

Title:	Ligands that modulate RAR receptors
Abstract:	Novel ligand compounds having the general formula (I): and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
Inventor(s):	Thibaud Biadatti, Laurence Dumais, Catherine Soulet, Sandrine Talano, Sebastien Daver
Assignee:	Galderma Research and Development SNC
Application Number:	US12/842,347
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 8,227,507

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 8,227,507

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
France	04 13848	Dec 23, 2004

International Family Members for US Patent 8,227,507

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1831149		301042	Netherlands
European Patent Office	1831149		CA 2020 00027	Denmark
European Patent Office	1831149		122020000029	Germany
European Patent Office	1831149		LUC00162	Luxembourg